With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Two former Pfizer executives published a statement saying they support the current company management as it gets pressured ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current ...

Pfizer (NYSE:PFE) CEO Albert Bourla is expected to meet with activist investor Starboard Value next week after the activist accumulated a $1 billion stake in the pharma giant. Bourla and at least ...

Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the COVID-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over ...